Inhibikase Therapeutics (IKT) Asset Utilization Ratio (2021 - 2024)
Inhibikase Therapeutics' (IKT) Asset Utilization Ratio stood at 0.00 in Q3 2024, down 100.0% from 0.02 a year earlier and down 100.0% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Asset Utilization Ratio (2021 - 2024) Analysis & Trends
For FY2023, Inhibikase Therapeutics' Asset Utilization Ratio came in at 0.01, up 260.6% from FY2022.
- Across earlier years, Asset Utilization Ratio came in at 0.00 in FY2022 (-96.6%) and 0.11 in FY2021.
- The Q3 2024 figure is the lowest quarterly Asset Utilization Ratio in data going back to Q1 2021.
- On a year-over-year basis, Asset Utilization Ratio rose in three of the last eight quarters, with growth averaging 105.5%.
- Peak year-over-year performance for Asset Utilization Ratio in the last five years was growth of 715.4% in Q3 2023, against a decline of 100.0% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 0.01 (Q2 2024), 0.02 (Q1 2024) and 0.02 (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 0.47 |
| 10 | Inhibikase Therapeutics | 359.62 Mn | -225.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.04 |
| Dec 31, 2021 | 0.07 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.10 |
| Mar 31, 2021 | 0.14 |
API Access
Inhibikase Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();